Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.
Judge DP, Gillmore JD, Alexander KM, Ambardekar AV, Cappelli F, Fontana M, García-Pavía P, Grodin JL, Grogan M, Hanna M, Masri A, Nativi-Nicolau J, Obici L, Hvitfeldt Poulsen S, Sarswat N, Shah K, Soman P, Lystig T, Cao X, Wang K, Pecoraro ML, Tamby JF, Katz L, Sinha U, Fox JC, Maurer MS. Judge DP, et al. Among authors: fontana m. Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072771. Online ahead of print. Circulation. 2024. PMID: 39556242 Free article.
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.
Fontana M, Solomon SD, Kachadourian J, Walsh L, Rocha R, Lebwohl D, Smith D, Täubel J, Gane EJ, Pilebro B, Adams D, Razvi Y, Olbertz J, Haagensen A, Zhu P, Xu Y, Leung A, Sonderfan A, Gutstein DE, Gillmore JD. Fontana M, et al. N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412309. Online ahead of print. N Engl J Med. 2024. PMID: 39555828
Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy.
Ioannou A, Razvi Y, Porcari A, Rauf MU, Martinez-Naharro A, Venneri L, Kazi S, Pasyar A, Luxhøj CM, Petrie A, Moody W, Steeds RP, Sperry BW, Witteles RM, Whelan C, Wechalekar A, Lachmann H, Hawkins PN, Solomon SD, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: fontana m. JAMA Cardiol. 2024 Nov 17:e244578. doi: 10.1001/jamacardio.2024.4578. Online ahead of print. JAMA Cardiol. 2024. PMID: 39550765 Free PMC article.
Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patients.
Sharrack N, Knott KD, Gulsin GS, Kotecha T, Brown LAE, Yeo JL, Porcari A, Adam RD, Thirunavukarasu S, Chowdhary A, Levelt E, Moon JC, McCann GP, Fontana M, Kellman P, Munyombwe T, Gale CP, Buckley DL, Greenwood JP, Swoboda PP, Plein S. Sharrack N, et al. Among authors: fontana m. Sci Rep. 2024 Nov 8;14(1):27280. doi: 10.1038/s41598-024-77280-2. Sci Rep. 2024. PMID: 39516499 Free PMC article.
Standardising health history and injury surveillance of participants in endurance events: a modified Delphi consensus statement from the AMSSM runner health consortium.
Tenforde AS, Kraus E, Kliethermes SA, Fontana MA, Barrack MT, Dubon M, Heikura IA, Hollander K, Kroshus E, Joachim MR, Lopes AD, Rauh MJ, Chastain R, Harrast M, Heiderscheit B, Krabak BJ, Miller EM, Napier C, Roberts WO, Roche D, Roche M, Schroeder AN, Taylor-Douglas D, Tenforde K, Verhagen E, Warden SJ, Willy RW, Toresdahl BG. Tenforde AS, et al. Among authors: fontana ma. Br J Sports Med. 2024 Nov 7:bjsports-2023-108059. doi: 10.1136/bjsports-2023-108059. Online ahead of print. Br J Sports Med. 2024. PMID: 39486880 Free article.
1,534 results